These findings align with studies showing that hypometabolism may predict cognitive decline independently of tau in sporadic AD and ADAD.34,35,73 The potential FDG-PET’s ability to independently predict cognitive decline might be explained by hypometabolism being closer in time to symptom onset compared to Aβ and tau accumulation. The gene discussed is MAPT; the disease is Alzheimer disease.